One study included 1800 CF patients who received CFTR modulators and showed a 67% and 62% reduction in AP hospitalizations in pancreatic-sufficient and pancreatic-insufficient CF patients, respectively [148]. The gene discussed is CFTR; the disease is cystic fibrosis.